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statistically signiﬁcant differences in preoperative age (High HHS 61 
11 vs. Low HHS 60 9 yrs, p¼0.793) BMI (High HHS 29 4 vs. Low HHS
28  6 kg/m^2, p¼0.924) or gender distribution (High HHS 3F/4M vs.
Low HHS 7F/4M, p¼0.387) between the two nonresponder groups.
There were no signiﬁcant differences in gait variables before surgery
(p¼0.215-p¼0.936) or after surgery (Figure 1). Pre-to-postoperative
change in gait variables did not differ between the groups (p¼0.140-
0.857).
Conclusions: Among THR subjects who were nonresponders, the 36%
with high preoperative HHS had similar gait variables to those with low
scores. Notably none of the responders had preoperative HHS  80.
Preoperative ﬁndings conﬁrm that the functional impairment that leads
some patients to seek THR may not be reﬂected in their clinical scores;
gait analysis may provide additional useful information. This work
further suggests that the OMERACT-OARSI response criteria indeed
capture meaningful functional recovery or residual impairment, even in
patients with high absolute scores. Patients with high preoperative
clinical scores may not always be considered good surgical candidates
because they may lack sufﬁcient capacity to improve. This study
suggests that good preoperative clinical status need not be a contrain-
dication for THR, but more work is needed to determine how to
measure and improve functional status in such patients.Figure 1. There were no differences in peak external moments between THR nonre-
sponders with high preoperative HHS (>¼80) or low preoperative HHS (<80). The
adduction, internal rotation and external rotation moments were signiﬁcantly reduced
in nonresponders compared to responders.183
DOES REDUCING CO-CONTRACTION DECREASE PAIN IN PATIENTS
WITH KNEE OSTEOARTHRITIS?
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Purpose: Previous research has consistently demonstrated elevated
levels muscle of co-contraction in patients with knee OA. The level of
co-contraction is typically highest between the medial hamstrings and
medial quadriceps and occurs during the early stance phase of walking.
It has been suggested that patients with knee OA increase muscle
activity in order to maintain knee joint stability. However, given that
increased co-contraction will increase loading across the knee joint, it
could equally be a maladaptive response which acts to maintain the
patient in a state of chronic pain. If this is the case thenwewould expect
decreases in co-contraction to be accompanied by reductions in clinical
pain.
The Alexander Technique (AT) is a method of movement re-education
which aims to alter patterns of muscle tension. A recent large scale trial
demonstrated that the AT can provide symptom relief for patients with
chronic low back pain and another study found the AT was able to
reduce spinal stiffness. This led the authors to suggest that AT may be
effective because it rebalances ongoing muscle activity (muscle tone).
Given the focus of the AT on patterns of muscle tension, it may be aneffective method for reducing increased co-contraction in patients with
knee OA.
We investigated whether the Alexander Techniquewould be effective at
reducing co-contraction and pain in patients suffering with knee OA. In
addition, we investigated whether any decreases in co-contraction
would be accompanied by decreases in pain.
Methods: A total of n¼11 patients (5 male) suffering with knee OAwere
recruited from primary care. Each patient underwent a baseline
biomechanical gait assessment after which they were given 20 lessons
of instruction in the AT. Each patient was then reassessed after the
intervention. At each of the two assessment points, EMG data were
collected and used to quantify the level of co-contraction during
walking between the quadriceps and hamstrings. In addition, kinematic
and kinetic data were collected for the lower extremity segments.
Clinical pain/disability was assessed using the WOMAC instrument and
individual pain scores were obtained by summing the items from the
WOMAC questionnaire which focus speciﬁcally on pain.
Results: Following instruction in the AT, there was a signiﬁcant
(p<0.01) reduction of 15% in medial co-contraction. However, no
changes were observed in lateral co-contraction or in any kinematic/
kinetic variables. In addition, there was a 56% decrease (p<0.01) from
45 to 20 in the WOMAC score and a decrease of 60% (p<0.01) in the
WOMAC pain score. The analysis revealed a relatively strong correlation
of r¼-0.67 (p<0.05) between the change in medial co-contraction and
the change in the WOMAC pain score.
Conclusions: The ﬁnding of a strong correlation suggests that the AT
was effective at reducing pain/disability because it reduced muscular
co-contraction. Although these ﬁnding suggest that elevated co-
contraction may be a maladaptive response, further work is needed to
understand whether reducing co-contraction in patients with knee OA
compromises knee joint stability. Although future large-scale studies
are required, our results demonstrate the potential for interventions,
such as the AT, which focus on reducing levels of muscle activity during
functional activity.184
LOWER LIMB STRENGTH AND GAIT BIOMECHANICS OF INDIVIDUALS
WITH END-STAGE HIP OSTEOARTHRITIS
F. Pozzi, S. Abujaber, P. Flowers, J. Zeni. Univ. of Delaware, Newark, DE,
USA
Purpose: To analyze the functional status and trunk, hip, and knee
biomechanics of subjects with end-stage hip osteoarthritis (OA) during
over-ground walking.
Methods: Six subjects (1 male, 5 females, 61.5  7.76 age, 1.66  0.02m
height, 77.3513.09kg weight) whowere scheduled for unilateral total
hip arthroplasty were recruited to participate in this study. The Hip
Harris Score was assessed for the surgical limb (SX) and pain in both
hips was assessed using a visual analog scale where 0 equaled no pain
and 10 equaled worst pain imaginable. Isometric hip abductor strength
was measured using a hand held dynamometer with the lower limbs
stabilized using a non-elastic belt. Isometric quadriceps strength was
measured using an electromechanical dynamometer. Strength
measures were taken bilaterally and themaximal value from three trials
was used in the analysis. Kinematic and kinetic data were collected
during over-ground walking at self-selected speed using an 8 camera
motion capture system and two force platforms. Trunk lateral lean and
sagittal and frontal plane kinematic and kinetic variables at the hip and
knee joints were calculated using inverse dynamics during the stance
phase of gait. Between limb differences for peak lateral trunk lean, peak
hip adduction, peak hip ﬂexion and peak external adduction hip
moment were analyzed using a paired-sample t-test. Pain and strength
were also compared between the SX and non-surgical (NSX) limbs
using a paired-sample t-test.
Results: The Hip Harris Score for the SX limb was 43  10%. The SX hip
was signiﬁcantly more painful than the NSX limb (mean differences
[MD]: 4.66  3.32, p¼.019, d¼1.40) and signiﬁcantly weaker (abductor
strength MD: -35.11  16.28 N, p¼.003, d¼-2.15). Differences between
limbs in quadriceps strength approached signiﬁcant levels with the SX
limb being -150.33  166.45 N weaker (p¼.078, d¼-0.90). On the SX
limb, subjects had greater lateral trunk lean (MD: -5.47  3.53 degree,
p¼.013, d¼2.01, ﬁgure 1A) and greater peak hip adduction (MD: 4.41 
2.19 degree, p¼.004, d¼1.54, ﬁgure 1B). Although peak hip extension
was highly variable, subjects tended to have less hip extension on the
SX limb (MD: -7.817.79 degree, p¼.074, d¼-0.92). Although no
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frontal plane moments at the hip joint, subjects demonstrated greater
external adduction moment at the knee of the SX side compared to the
NSX side (MD: 0.12  0.11 Nm/Kg, p¼.013, d¼1.09).
Conclusions: The Hip Harris Score, pain level, and abductor strength
suggest that the SX hip is more impaired than the NSX limb. Subjects
also ambulate with a compensatory lateral trunk lean toward the
affected limb, but continue to demonstrate greater adduction angles on
the SX limb during single limb stance. These movement abnormalities
may represent the primary movement impairments and may be related
to the unilateral hip abductor weakness observed in this sample.
Unilateral impairments may also contribute to the signiﬁcantly larger
knee adduction moment on the NSX limb.Figure 1. Average trunk lean angle (A) and hip frontal plane angle (B) during the
stance phase of gait for the surgical limb (solid black line) and non-surgical limb
(dashed red line). Positive angles represent lean toward the stance leg (A) and
adduction (B). Black-striped area represents the standard deviation for the surgical
limb. Red-squared area represents the standard deviation for the non-surgical limb.185
THE TRANSIENT EFFECTS OF COX-2 INHIBITOR ON OSTEOGENIC
DIFFERENTIATION IN CANINE BONE MARROW-DERIVED
MESENCHYMAL STEM CELLS
N. Oh, T. Sunaga, S. Kim, K. Hosoya, M. Okumura. Hokkaido Univ.,
Sapporo, Japan
Purpose: Nonsteroidal anti-inﬂammatory drugs (NSAIDs), especially
cyclooxygenase (COX)-2 inhibitors, are simple and effective analgesics
in orthopedic ﬁelds. Last decades, the effects of COX-2 inhibitor on bone
healing process have remained controversial, while rare clinical data
represent relationship between COX-2 inhibitor and bone healing. The
aim of this study was to assess the effects of COX-2 inhibitors, such as
carprofen (Cp) and meloxicam (Mx), on osteogenic differentiation of
canine bone marrow-derived mesenchymal stem cells (BMSCs).
Methods: Canine BMSCs were harvested from three one-year-old
female beagle dogs. Osteogenic differentiation of canine BMSCs was
induced by osteogenic medium containing dexamethasone (100 nM), b-
glycerophosphate (10 mM), ascorbic acid (50 mg/ml) and human
recombinant IL-1b (1 ng/ml) as an inﬂammatory stimulator. The
maximum concentration of Cp (10 mM) or Mx (10 mM) that had no effect
on cell viability was treated within short- and long-term of osteogenic
process. The mRNA expressions of osteoblastic marker, involving alka-
line phosphatase (ALP) and osteocalcin, and prostaglandin E2 receptor
subtypes, such as EP2 and EP4, were measured using quantitative
reverse transcription-polymerase chain reaction (qRT-PCR). For the
histological evaluation, ALP staining and von Kossa staining were
performed.
Results: Expressions of mRNA of ALP and osteocalcin were signiﬁcantly
suppressed by use of COX-2 inhibitors. Alkaline phosphatase staining
revealed that COX-2 inhibitors partially arrested early differentiation of
osteoblast lineage. However, gene expressions of EP2 and EP4 were up-
regulated under COX-2 inhibition, and delayed osteogenic differentia-
tion was gradually recovered after withdrawal of COX-2 inhibitors.
Calciﬁcation of matrix showed no signiﬁcant difference between short-
term treated group and control at the late period of osteogenic
differentiation.
Conclusions: These data suggest that canine BMSCs might have
potential to catch-up the osteogenic differentiation and to up-regulate
osteogenic gene expression after withdrawal of COX-2 inhibitors.186
IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-18 AS
A MOLECULE TO PROTECT AND REGENERATE ARTICULAR CARTILAGE
Y. Mori y, T. Saito y, C. Ladel z, H. Guehring z, U-i. Chung y,
H. Kawaguchi y. y Faculty of Med., Univ. of Tokyo, Tokyo, Japan; zMerck
KGaA, Darmstadt, Germany
Purpose: Aiming at the disease-modifying treatment of osteoarthritis
(OA), we sought to identify genes that maintain the homeostasis of
adult articular cartilage and regenerate its lesions by gene expression
proﬁle analyses. The mechanisms of the identiﬁed molecule underlying
the protection and regeneration were further investigated.
Methods: To identify genes that have both protective and regenerative
effects on adult articular cartilage, we performed two sets of microarray
analyses. First, to select genes that work for maintenance of articular
cartilage, we compared gene expression proﬁles between adult artic-
ular (AA) and adult growth plate (AG) cartilages in 10-week-old rats.
Second, to ﬁnd genes that function for regeneration of articular carti-
lage, we compared the proﬁles between infant superﬁcial (IS) and infant
deep (ID) layers of epiphyseal cartilage in 6-day-old rats. For genes
which were up-regulated 10-fold both in AA than in AG and in IS than
in ID, we performed real-time RT-PCR for the conﬁrmation. In vivo
expression was examined by immunohistochemistry of articular and
growth plate cartilage of 14-week-old rats. The therapeutic effect of
intra-articular injection of sprifermin (recombinant human ﬁbroblast
growth factor 18 (FGF18)) was examined in the experimental OA model
by surgical induction of instability in the knee joints of adult rats. To
further learn the underlying mechanism, the protective ability of
articular cartilage was assessed by measuring the amount of sulfated
glycosaminoglycan (sGAG) released into the medium in the ex vivo
culture of bilateral femoral heads of 3-week-old mice using dimethyl-
methylene blue dye-binding assay. Proliferation and migration were
analyzed in the cultures of mouse articular chondrocytes using Cell
Counting Kit-8 and Oris Cell Migration assay systems, respectively.
Expression levels of catabolism-related factors (Mmp9, Mmp13,
Adamts4, Adamts5, Timp1, Timp2, and Timp3) and anabolism-related
factors (Col2a1 and aggrecan) in the cultures of mouse femoral heads
and mouse articular chondrocytes were analyzed by real-time RT-PCR.
Results: Microarray analyses revealed that 40 and 186 genes had 10-
fold higher expression ratios of AA/AG and IS/ID, respectively, and 16
genes showed 10-fold of both AA/AG and IS/ID ratios. The ratios of the
16 genes were conﬁrmed to be 10 fold by real-time RT-PCR analysis.
Among them three genes were expressed more strongly in AA than in
IS. In these three genes, FGF18 was the extracellular and secreted factor
of which the AA/AG ratio was the highest in the microarray analysis.
Immunohistochemistry showed that FGF18 was strongly expressed in
the articular cartilage chondrocytes of adult rats but was hardly
detected in the growth plate cartilage. In the rat surgical OA model,
a once-weekly injection of sprifermin given 3 weeks post-surgery
prevented cartilage degeneration in a dose-dependent manner at 6 and
9 weeks after surgery, with a signiﬁcant effect at 10 mg/week of spri-
fermin. As an underlying mechanism, sprifermin suppressed the sGAG
release into the culture medium in the ex vivo culture of mouse femoral
heads. Furthermore, sprifermin accelerated proliferation and migration
of cultured mouse articular chondrocytes. Among catabolic and
anabolic factors, sprifermin decreased Adamts4 and increased Timp1
expressions in the cultures of mouse femoral heads and murine artic-
ular chondrocytes; however it decreased Col2a1 and aggrecan expres-
sions in both cultures.
Conclusions: The present gene expression proﬁling analysis identiﬁed
sprifermin as a molecule to protect and regenerate adult articular
cartilage, causing prevention of cartilage degeneration by the once-
weekly intra-articular injection in a rat model. This effect may be due to
inhibition of cartilage catabolism, and acceleration of proliferation and
migration of articular chondrocytes, providing a disease-modifying OA
treatment.
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OLD AND YOUNG ARTICULAR CARTILAGE RESPOND EQUIVALENTLY
FOR PHYSIOLOGICAL AND EXCESSIVE LOADING BY ACTIVATION OF
PROTECTIVE TGF-BETA SIGNALING
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